289P Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studiesC.A. Powell,D.R. Camidge,S. Modi,A. Qin, C. Taitt,C. Lee, M.D. Hackshaw,J. Singh,H. IwataAnnals of Oncology(2020)引用 15|浏览25暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要